cochlear acquires oticon medical

Cochlear to Acquire Oticon Medical as Demant Divests Implants Business

Demant announced today that it has negotiated an agreement with the intention to divest its Hearing Implants business, Oticon Medical, to Cochlear Limited for a total consideration of DKK 850 million ($120M USD). The transaction follows a review of strategic options for the business area, including how to ensure the best lifelong support of existing…

Read More
bone anchored awareness day

Oticon Medical Invites Everyone to Feel the Good Vibrations on Bone Anchored Awareness Day

SOMERSET, NEW JERSEY — May 3rd marks the second annual Bone Anchored Awareness Day, also known as Good Vibrations Day. This day was established in 2021 as a non-branded day to raise awareness, celebrate bone anchored hearing as a treatment, and give voice to users around the globe. The May 3rd date was specifically chosen…

Read More
oticon medical ponto 5 superpower

Oticon Medical Announces FDA Clearance of Ponto 5 SuperPower

SOMERSET, NEW JERSEY – Oticon Medical announces that the U.S. Food and Drug Administration (FDA) has cleared the new Ponto 5 SuperPower sound processor, expanding the Ponto 5 family product line. According to the announcement, the device would be the smallest SuperPower device available, which also delivers “significant advancements in sound processor technology – including…

Read More
demant

Demant Releases 2021 Interim Financial Report

KONGEBAKKEN, DENMARK — Demant A/S announced the release of its 2021 Interim Report this week. The company reported organic growth of 51% in the first half (H1) of the year, and market share gains in Hearing Healthcare. The recovery in the global hearing healthcare market for H1 was in line with expectations. EBIT of DKK 1,638 million…

Read More

Oticon Medical Announces FDA Premarket Approval for Neuro Cochlear Implant System

SOMERSET, NEW JERSEY — Oticon Medical today announced that the US Food and Drug Administration (FDA) has granted premarket approval (PMA) to the company’s Neuro System to treat individuals 18 years or older, with bilateral severe-to-profound sensorineural hearing loss, who obtain limited benefit from appropriately fitted hearing aid(s). With the expansion of its cochlear implant…

Read More
oticon medical blog

Oticon Medical Launches New Blog for Hearing Healthcare and Medical Professionals

Oticon Medical has announced the launch of its new blog, Hearing Implant Updates for Professionals. The blog has been designed as an added way to engage Oticon Medical’s current and potential professional customers, and will provide topics of interest for hearing healthcare professionals and other medical professionals who wish to learn more about hearing implant…

Read More
oticon medical us president

John Sparacio Named President of Oticon Medical US

SOMERSET, NEW JERSEY — Oticon Medical US announced that it has named John Sparacio as President. In his new role, Sparacio will be responsible for leading the organization and advancing the company’s position in bone anchored hearing systems and cochlear implant solutions in the US market. He will report directly to Mikael Worning, President of…

Read More

CMS backs down; will preserve Medicare coverage of bone-anchored hearing systems

By David H. Kirkwood WASHINGTON, DC—Responding to a broad-based national campaign by manufacturers, hearing care providers, and consumer advocates, the Centers for Medicare and Medicaid Services (CMS) announced on October 31 that it had reversed its position and would not end Medicare coverage of auditory osseointegrated implants (AOIs). As previously reported on this blog, CMS…

Read More